The drug development landscape in Parkinson's

This event will be held in person. Please note slightly the later start time of 12:15pm

Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (, a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.